Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy.
Saved in:
| Title: | Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy. |
|---|---|
| Authors: | Graff JN; VA Portland Health Care System, Portland, OR, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States., Stein MN; Columbia University Medical Center, New York, NY, United States., Surana R; MD Anderson, Houston, TX, United States., Al Rabadi L; VA Portland Health Care System, Portland, OR, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States., Liu E; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., Fong L; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., Bailey S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States., Latour E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States., Newby TA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States., Moran AE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States., Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2020 Aug 07; Vol. 10, pp. 1381. Date of Electronic Publication: 2020 Aug 07 (Print Publication: 2020). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
